Publications de 2012

1.     Vidal N, Diop H, Montavon Cl, Butel C, Bosch Sp, Ngole EM, Tour√©-Kane C, Mboup S, Delaporte E, and Peeters M. A novel Multiregion Hybridization Assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa.
Infection, Genetics and Evolution (2012); (http://dx.doi.org/10.1016/j.meegid.2012.11.017 ).
 
2.     Ongolo-Zogo P, Nkodo Mbia N, Mvogo Minkala TL, Biwole Sida M, Kouanfack C, Nko Amvene S.
Bull Soc Pathol Exot. 2012 Dec;105(5):353-60. doi: 10.1007/s13149-012-0253-x. Epub 2012 Aug 10.
 
3.     Ndziessi G, Boyer S, Kouanfack C, Cohen J, Marcellin F, Moatti JP, Delaporte E, Spire B, Laurent C, and Carrieri MP. Adherence as a Predictor of Sexual Behaviors in People Living with HIV/AIDS during the First Year of Antiretroviral Therapy in Rural Cameroon: Data from Stratall ANRS 12110/ESTHER Trial. PloS one (2012); 7(6):e36118.
 
4.     Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti JP, Marcellin F, Laurent C, Spire B, Delaporte E, and Carrieri MP. Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon – Data from the STRATALL ANRS 12110/ESTHER trial.
AIDS CARE (2012); 09 Jul
 
5.     Monleau M, Aghokeng AF, Nkano BA, Chaix ML, and Peeters M
Drug resistance mutations of HIV-1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-Saharan countries and discordant interpretations.
AIDS Res Hum Retroviruses (2012); 28(9):957-960
 
6.     Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C.
PLoS One. 2012;7(12):e46909. doi: 10.1371/journal.pone.0046909. Epub 2012 Dec 6.
 
7.     Mben JM, Kouanfack C, Essomba CN, Mbougua JB, Kenfack A, Tonfack CA, Laborde-Balen G, Bourgeois A, Biwole-Sida M, Delaporte E, and Laurent C
Operational research and HIV policy and guidelines: Lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon.
J Public Health Policy (2012); 33(4):462-77.
 
8.     Lewden C, Gabillard D, Minga A, Ekouevi DK, Avit D, Konate I, Amani-Bosse C, Messou E, Coffie P, Ouedraogo A, Laurent C, and Anglaret X
CD4-Specific Mortality Rates Among HIV-Infected Adults With High CD4 Counts and No Antiretroviral Treatment in West Africa.
J Acquir Immune Defic Syndr (2012); 59(2):213-219.
 
9.     Lorente N, Henry E, Fugon L, Yomb Y, Carrieri MP, Eboko F, Spire B.
AIDS Care. 2012;24(8):1020-7. doi: 10.1080/09540121.2012.668172. Epub 2012 Apr 23.
 
10.   Laurent C, Kouanfack C, Molinari N, Koulla-Shiro S, Delaporte E, and for the Stratall ANRS 12110/ESTHER study group
HIV laboratory monitoring for effective ART in Africa – Authors’ reply.
Lancet Infect Dis (2012); 12(6):430-1.
 
11.   Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngole E, Ducos J, Delaporte E, and Laurent C
Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
Antivir Ther (2012); 17(2):321-6.
 
12.   Kfutwah AK, Tejiokem MC, Njouom R.
Virol J. 2012 Mar 8;9:62. doi: 10.1186/1743-422X-9-62.
 
13.   Etienne L, Locatelli S, Ayouba A, Esteban A, Butel C, Liegeois F, Aghokeng A, Delaporte E, Mpoudi Ngole E, and Peeters M
Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated Western lowland gorillas in cameroon.
J Virol (2012); 86(18):9760-72.
 
14.   Ekali LG, Johnstone LK, Echouffo-Tcheugui JB, Kouanfack C, Dehayem MY, Fezeu L, Nouthe B, Hayes L, Unwin NC, Sobngwi E.
Diabetes Metab. 2012 Nov 12. doi:pii: S1262-3636(12)00159-0. 10.1016 /j.diabet.2012.08.012
 
15.   Djoko CF, Wolfe ND, Aghokeng AF, Lebreton M, Liegeois F, Tamoufe U, Schneider BS, Ortiz N, Mbacham WF, Carr JK, Rimoin AW, Fair JN, Pike BL, Mpoudi-Ngole E, Delaporte E, Burke DS, and Peeters M
Failure to Detect Simian Immunodeficiency Virus Infection in a Large Cameroonian Cohort with High Non-human Primate Exposure.
Ecohealth (2012); 9(1):17-23.
     
16.   Boyer S, Protopopescu C, Marcellin F, Carrieri MP, Koulla-Shiro S, Moatti JP, Spire B; EVAL Study Group.
Health Policy Plan. 2012 Jul;27(4):301-15. doi: 10.1093/heapol/czr039.
 
17.   Billong SC, Fokam J, Nkwescheu AS, Kembou E, Milenge P, Tsomo Z, Dion GN, Aghokeng AF, Mpoudi EN, Ndumbe PM, Colizzi V, and Elat Nfetam JB
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
PLoS One (2012)7(5):e36777.
 
18.   Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Remy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, and Mallie M
Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
Clin Microbiol Infect 2012 Sep 1.  doi: 10.1111/1469-0691.12019.
 
19.   Ayouba A, Mouacha F, Learn GH, Mpoudi-Ngole E, Rayner JC, Sharp PM, Hahn BH, Delaporte E, and Peeters M
Ubiquitous Hepatocystis infections, but no evidence of Plasmodium falciparum-like malaria parasites in wild greater spot-nosed monkeys (Cercopithecus nictitans).
Int J Parasitol (2012); 42(8):709-13.